Kijin Jang

Kijin Jang

Auto-generated profile, based on publicly available information

Kijin Jang

The Louma G. Laboratory of Epigenetic Research, Faculty of Medicine, University of Iceland, Reykjavik, Iceland

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
SRSalvor Rafnsdottir
Salvor Rafnsdottir
KJKijin Jang
Kijin Jang
SHSara Tholl Halldorsdottir
Sara Tholl Halldorsdottir
MVMeghna Vinod
Meghna Vinod
ATArnhildur Tomasdottir
Arnhildur Tomasdottir
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
Organisms have homeostatic mechanisms to respond to cold to ensure survival including the activation of the neuroprotective mild hypothermia response (MHR) in mammals at 32°C. We show activation of the MHR by one FDA-approved medication, Entacapone, a proof-of-principle that the MHR can be medically manipulated. Utilizing a forward CRISPR-Cas9 mutagenesis screen, we identify the histone lysine methyltransferase SMYD5 as an epigenetic gatekeeper of the MHR. SMYD5 represses the key MHR gene SP1 at euthermia but not at 32°C. This repression is mirrored by temperature-dependent levels of H3K36me3 at the SP1-locus and globally indicating the mammalian MHR is regulated at the level of histone modifications. We identified 45 additional SMYD5-temperature dependent genes suggesting a broader MHR-related role for SMYD5. Our study provides an example of how the epigenetic machinery integrates environmental cues into the genetic circuitry of mammalian cells and suggests novel therapeutic avenues for neuroprotection after catastrophic events.

3 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
KJKijin Jang
Kijin Jang
KOKevin Ostacolo
Kevin Ostacolo
VSValdimar Sveinsson
Valdimar Sveinsson
MBMichael Beer
Michael Beer
KAKimberley Anderson
Kimberley Anderson
HBHans Tomas Bjornsson
Hans Tomas Bjornsson
The mild hypothermia response (MHR) is a conserved mammalian cytoprotective program activated upon exposure to mild hypothermia (32 °C) that contributes to the neuroprotective effects of therapeutic hypothermia following hypoxic injury. Although rapid changes in intracellular calcium occur upon cooling, the mechanisms linking calcium dynamics to the activation of core MHR factors such as SP1 and RBM3 remain incompletely defined. In this study, we used siRNA-mediated knockdown (KD) of candidate regulators in conjunction with novel mild hypothermia indicator (MHI) reporters to identify upstream modulators of MHR-associated transcription. We identify SARAF, a negative regulator of store-operated calcium entry (SOCE), as a repressor of both SP1 and RBM3 under normothermic conditions. SARAF depletion is associated with increased intracellular calcium release and enhanced SP1- and RBM3-linked transcriptional outputs. We identify JUN as an important downstream factor mediating SARAF depletion-dependent de-repression of the MHR and demonstrate that it undergoes activation rapidly upon cooling. Finally, SARAF depletion conferred significant cytoprotection against hypoxia-induced early apoptosis. Collectively, these findings establish SARAF as an upstream regulator of MHR-associated transcription and provide a functional link between cold-induced intracellular calcium dynamics and the induction of core MHR effectors.